幸运8平台彩票 The AlphaLISA® immunoassay kit for IL17F is designed for the quantitative determination of human IL17F in human serum, plasma, cell lysate, and cell culture supernatants using a homogeneous AlphaLISA assay (no wash steps). The assay shows no cross-reactivity with human IL-17A and with mouse IL17F, bovine IL17F, and rat IL17F. Cross-reactivity with other species has not tested.
幸运8平台彩票 For research use only. Not for use in diagnostic procedures.
IL17F, also known as human interleukin 17, is a pro-inflammatory cytokine produced by T-helper cells. This cytokine has been found to inhibit the angiogenesis and endothelial cells and induce endothelial cells to produce other cytokines. Levels of this cytokine play an important role in asthma and chronic inflammatory disease such as psoriasis, multiple sclerosis, and rheumatoid arthritis. The present kit is designed to detect IL17F in serum, plasma, cell culture supernatants, and cell lysates.
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
|产品尺寸||5,000 assay points|